Postoperative pancreatic fistula-impact on outcome, hospital cost and effects of centralization.
One of the most serious complications after pancreaticoduodenectomy (PD) is postoperative pancreatic fistula (POPF). This study investigated the incidence of POPF before and after centralization of pancreatic surgery in Southern Sweden and its impact on outcome and health care costs.



The local registry comprising all pancreatic resections at Skåne University Hospital, Lund, Sweden, was searched for PDs from 2005 to 2015. The patients were analysed in three groups: low-volume, high-volume and after introduction of an enhanced recovery program. Only the clinically relevant POPF grades B and C (CR-POPF) were investigated.



322 consecutive patients were identified. The annual operation volume increased almost threefold and the postoperative length of stay and total hospital cost decreased concurrently. The incidence of CR-POPF did not decrease over time. The group with CR-POPF had more complications and prolonged length of stay. The cost was 1.5 times higher for patients with CR-POPF and the cost did not decline despite the increase of hospital volume.



Centralization of pancreatic surgery did not decrease the rate of CR-POPF nor its subsequent impact on LOS and costs. Further efforts must be made to reduce the incidence of CR-POPF.
Department of Surgery, Skåne University Hospital at Lund and Clinical Sciences, Lund University, Sweden.
Caroline
C
Williamsson
Department of Surgery, Skåne University Hospital at Lund and Clinical Sciences, Lund University, Sweden.
Daniel
D
Ansari
Department of Surgery, Skåne University Hospital at Lund and Clinical Sciences, Lund University, Sweden.
Roland
R
Andersson
Department of Surgery, Skåne University Hospital at Lund and Clinical Sciences, Lund University, Sweden. Electronic address: bobby.tingstedt@med.lu.se.
Bobby
B
Tingstedt
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002497:Centralized Hospital Services / Q000191:economics*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D005260:Female; D017721:Hospital Costs; D061847:Hospitals, High-Volume; D061846:Hospitals, Low-Volume / Q000191:economics; D006785:Hospitals, University / Q000191:economics; D006801:Humans; D015994:Incidence; D007902:Length of Stay / Q000191:economics; D008297:Male; D008875:Middle Aged; D010185:Pancreatic Fistula / Q000175:diagnosis / Q000191:economics* / Q000453:epidemiology* / Q000628:therapy; D016577:Pancreaticoduodenectomy / Q000009:adverse effects* / Q000191:economics*; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult